Delivery Order SPE2DB24D6038-SPE2DB25FELKH

Award Date 11/21/24
Potential Completion Date 11/22/24
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ADDYI 100 MG TABLET in quantities of 30 tablets. The fixed-price contract has a ceiling value of $11,614.44 and an ultimate completion date of March 17, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply ADDYI 100 MG TABLET pharmaceuticals. The $3,199.38 order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to AmerisourceBergen Drug Corp by DLA to provide a comprehensive range of medications and medical supplies to military treatment programs and facilities worldwide....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ADDYI 100 MG Tablets. The contract has a ceiling value of $3,997.59 and a period of performance through March 2024. The contract is a firm-fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a $2,775.75 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ADDYI 100 MG TABLET UU 30S, a medication, with a completion date of April 2, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 mg ADDYI tablets in 30-count units, with a ceiling value of $3,519.22 and a completion date of May 22, 2025. The contract is a firm fixed-price type and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $5,436.06 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565333877 ADDYI 100 MG TABLET UU 30S. This delivery order falls under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,624.46, is for the delivery of ADDYI 100 MG TABLET with a completion date of June 17, 2025. The contract is a firm fixed-price delivery order, and it is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ADDYI 100 MG TABLET in units of 30, with a firm fixed price of $1,935.74 and a performance period through June 18, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADDYI 100 MG TABLET UU 30S, a pharmaceutical product, with a ceiling value of $24,422.86 and a performance period through June 12, 2025. The contract is a Firm Fixed Price, non-set-aside award. AmerisourceBergen Drug Corp also holds a larger Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,382.32, is for the delivery of ADDYI 100 MG TABLET UU 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of September 17, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB24D6038
    Indefinite Delivery Contract
  • SPE2DB24D6038-SPE2DB25FELKH
    Delivery Order

This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ADDYI 100 MG TABLET UU 30S. The firm fixed-price contract has a ceiling value of $3,720.22 and a completion date of November 22, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This particular order does not have a set-aside designation, indicating open competition. The contract award demonstrates Amerisourcebergen's role as a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems, through its extensive supply chain and distribution capabilities.

Generated 5/20/25, 2:19 PM